Edurne Novella-Maestre

No ORCID on file · 14 papers in corpus · active 2007-2020

Study types

  • article 11
  • book-chapter 2
  • book 1

Condition tags

  • endometriosis 13
article 2020
Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2020.06.020
article 2016
ORIGINAL ARTICLE Gynaecology

Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

article 2012
Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.07.1103
article 2012
SESSION 74: ENDOMETRIOSIS/ENDOMETRIUM: MOLECULAR AND CELLULAR INSIGHTS 3
·doi:10.1093/humrep/27.s2.72
book-chapter 2011
Antiangiogenic agents for endometriosis
·doi:10.1017/cbo9780511734755.011

This chapter addresses the controversies surrounding the impact and surgical management of hydrosalpinges and uterine leiomyoma on in vitro fertilization (IVF) cycle outcome. Evidence accumulated over the last 15 years suggests that either …

book 2011
Human Assisted Reproductive Technology
·doi:10.1017/cbo9780511734755

Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice offers a collection of concise, practical review articles on cutting-edge topics within reproductive medicine. Each article presents a balanced view o…

article 2011
POSTER VIEWING SESSION - ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE
·doi:10.1093/humrep/26.s1.80
book-chapter 2010
Antiangiogenic Agents in Endometriosis
·doi:10.5005/jp/books/11032_31
article 2010
Identification and Quantification of Dopamine Receptor 2 in Human Eutopic and Ectopic Endometrium: A Novel Molecular Target for Endometriosis Therapy1
Biology of reproduction ·doi:10.1095/biolreprod.110.084392

Previous studies in an experimental mouse model of endometriosis have shown that the dopamine agonist (DA) cabergoline (Cb2) reduces angiogenesis and endometriotic lesions, hypothetically binding to the dopamine receptor type-2 (DRD2). To d…

article 2010
Reply: Rectal endometriosis and prolactinoma
·doi:10.1093/humrep/deq066
article 2009
Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis
Human Reproduction ·doi:10.1093/humrep/den499

BACKGROUND: Implantation of a retrogradely-shed endometrium during menstruation requires an adequate blood supply. The endometrium has angiogenic potential, and endometriotic lesions grow in areas with a rich vascularization, suggesting tha…

article 2009
Dopamine Agonist Administration Causes a Reduction in Endometrial Implants Through Modulation of Angiogenesis in Experimentally Induced Endometriosis
·doi:10.1097/01.ogx.0000359267.83853.0f

Survival of newly implanted retrograde–shed endometrial tissue during menstruation in an ectopic location requires an adequate blood supply. This suggests that angiogenesis is a prerequisite for the development of endometriosis and that its…

article 2007
Modulation of angiogenesis by the dopamine agonist Cabergoline in experimentally-induced peritoneal endometriotic lesions
·doi:10.1016/j.fertnstert.2007.07.141
article 2007
Session 31: Endometriosis 1
·doi:10.1093/humrep/dem1030

also sensitized ESC to Fas-mediated apoptosis, but this effect seems not to be mediated by the downregulation of FLIP, an inhibitor of caspase-8 activation. Conclusion: In summary, we demonstrate that human ESC are primarily resistant to ap…